Mice Deficient in Inducible Nitric Oxide Synthase Are Susceptible to Experimental Autoimmune Uveoretinitis

7. Cartwright MJ, Grajewski AL, Friedberg ML, Anderson DR, Rich-ards DW. Immune-related disease and normal-tension glaucoma.Arch Ophthalmol. 1992; 110:500-502.8. Wax MB, Barrett DA, Pestronk A. Increased incidence of parapro-teinemia and autoantibodies in patients with normal pressureglaucoma. Am JOphthalmol. 1994;117:56l-578.9. Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heatshock protein antibodies in patients with normal-pressure glau-coma. Am J Ophthalmol. 1998;125:l45-157.10. Tezel G, Seigel G, Wax MB. Autoantibodies to small heat shockproteins in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2277-2287.11. Romano C, Barrett DA, Li Z, Pestronk A, Wax MB. Anti-rhodopsinantibodies in sera from patients with normal-pressure glaucoma.Invest Ophthalmol 1995 Vis 36:196; 8 -1975 Sci. .12. Tezel G, Kass MA, Kolker AE, Wax MB. Comparative optic discanalysis in normal pressure glaucoma, primary open-angle glaucoma,and ocular hypertensioa Ophthalmology. 1996;103:2105-2113.13. Adamus G, Zam ZS, Arendt A, et al. Anti-rhodopsin monoclonalantibodies of defined specificity: characterization and application.Vision Res. 1991;31:17-31.14. Litman BJ. Purification of rhodopsin by concanavalin A affinitychromatography. MethodsEnzymol. 1982;81:150-153.15- Hargrave PA, Adamus G, Arendt A, et al. Rhodopsin's amino ter-minus is a principal antigenic site. Exp Eye Res. 1986;42:363-373-16. Adamus G, Arendt A, Hargrave PA. Genetic control of antibodyresponse to bovine rhodopsin in mice: epitope mapping of rho-dopsin structure. / Neuroimmunol. 1991;34:89-97.17. Marrack P, Kappler J. Subversion of the immune system by patho-gens. Cell. 1994;76:323-332.18. Oldstone MB. Molecular mimicry and autoimmune disease. Cell.1987;50:819-820.19. Young DB. Heat-shock proteins: immunity and autoimmunity.Curr Opin Immunol. 1992;4:396-400.20. Alvis DL. Electroretinographic changes in controlled chronic open-angle glaucoma. AmJ Ophthalmol. 1966;61:121-131.21. Bartl G. The electroretinogram and the visual evoked potential innormal and glaucomatous eyes. Albrecht Von Graefes Arch KlinExp Ophthalmol. 1978;207:243-269.22. Fazio DT, Heckenlively JR, Martin DA, Christensen RE. The elec-troretinogram in advanced open-angle glaucoma. Doc Ophthal-mol, 1986;63:45-54.23. Odom JV, Feghali JG, JinJC, Weinstein GW. Visual function deficitsin glaucoma. Electroretinogram pattern and luminance nonlineari-ties. Arch Ophthalmol. 1990;108:222-227.24. Holopigian K, Seiple W, Mayron C, Koty R, Lorenzo M. Electro-physiological and psychophysical flicker sensitivity in patientswith primary open-angle glaucoma and ocular hypertension. In-vest Ophthalmol Vis Sci. 1990:31:1863-1868.25- Nork TM, Poulsen GL, Vaegen, Sarks S. Photoreceptor damage andloss in human eyes with primary open angle glaucoma [ARVOAbstract]. Invest Ophthalmol Vis Sci. 1995;36(4):S331. Abstract nr1546.26. Janssen P, Naskar R, Moore S, Thanos S, Thiel HJ. Evidence forglaucoma-induced horizontal cell alterations in the human retina.GerJ Ophthalmol. 1996;5:378-385.27. Kendell KR, Quigley HA, Kerrigan LA, Pease ME, Quigley EN.Primary open-angle glaucoma is not associated with photoreceptorloss. Invest Ophthalmol Vis Sci. 1995:36:200-205.28. Hargrave PA, McDowell JH. Rhodopsin and phototransduction: amodel system for G protein-linked receptors. FASEB J. 1992;6:2323